92609 ⎘
Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
Sub-classes:NON-LINEAR PEGYLATED LIPID CONTAINING A TERTIARY AMINE AND APPLICATION THEREOF
#2CATIONIC LIPIDS FOR NUCLEIC ACID DELIVERY AND PREPARATION THEREOF
#3NITROGEN-BRANCHED NON-LINEAR PEGYLATED LIPID CONTAINING A TERTIARY AMINE AND APPLICATION THEREOF
#4MODIFIED AMINE LIPIDS
#5CATIONIC LIPIDS FOR NUCLEIC ACID DELIVERY AND PREPARATION THEREOF
#6NANOMATERIALS COMPRISING ACETALS
#7DNP and DNP Prodrug Treatment of Neuromuscular, Neurodegenerative, Autoimmune, Developmental, Traumatic Brain Injury, Concussion, Dry Eye Disease, Hearing Loss and/or Metabolic Diseases
#8Modified amine lipids
#9Lipids and lipid compositions for the delivery of active agents
#10Carbondisulfide derived zwitterions
#11DNP and DNP prodrug treatment of neuromuscular, neurodegenerative, autoimmune, developmental, traumatic brain injury, concussion, dry eye disease, hearing loss and/or metabolic diseases
#12Cationic lipids for nucleic acid delivery and preparation thereof
#13Carbondisulfide derived zwitterions
#14Lipids and lipid compositions for the delivery of active agents
#15Lipids and lipid compositions for the delivery of active agents
#16Carbondisulfide derived zwitterions
#17Use of cannabidiol prodrugs in topical and transdermal administration with microneedles
#18Reactive ionic liquids
#19Pharmaceutically acceptable salts of fatty acids
#20Compound having acridan ring structure, and organic electroluminescent device
#21DYRK1 inhibitors and uses thereof
#22Compound having acridan ring structure, and organic electroluminescent device
#23USE OF CANNABIDIOL PRODRUGS IN TOPICAL AND TRANSDERMAL ADMINISTRATION WITH MICRONEEDLES
#24Reactive ionic liquids
#25Prodrugs of cannabidiol, compositions comprising prodrugs of cannabidiol and methods of using the same
#26Cationic cardiolipin analoges and its use thereof